Up-Regulation of Endothelial Nitric Oxide Synthase through β2-Adrenergic Receptor—The Role of a β-Blocker with NO-Releasing Action

This publication has 20 references indexed in Scilit:

• Nipradilol: A β‐Adrenoceptor Antagonist with Nitric Oxide–Releasing Action
  Cardiovascular Drug Reviews, 1998
• The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
  Archives of internal medicine (1960), 1997
• The β adrenoreceptor antagonist, nipradilol, preserves the endothelial nitric oxide response in atherosclerotic vessels of rabbit
  Life Sciences, 1997
• Structure and magnetic properties of TbMn6−xAlxSn6 compounds
  Journal of Applied Physics, 1997
• Induction of angiogenesis by smooth muscle cell‐derived factor: Possible role in neovascularization in atherosclerotic plaque
  Journal of Cellular Physiology, 1995
• Efficacy of long-term treatment with nipradilol, a nitroester-containing beta-blocker, in patients with mild-to-moderate essential hypertension
  Clinical Therapeutics, 1995
• Contribution of cyclic GMP generation to the relaxation by nipradilol in the rabbit aorta
  General Pharmacology: The Vascular System, 1995
• Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension.
  Journal of Clinical Investigation, 1993
• Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: implications for atherosclerosis.
  Proceedings of the National Academy of Sciences, 1992
• β-Blocking Agents with Vasodilating Action
  Journal of Cardiovascular Pharmacology, 1992